ProfileGDS4718 / 233269_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 64% 74% 23% 68% 72% 37% 27% 71% 73% 73% 63% 70% 40% 32% 31% 33% 75% 18% 14% 17% 70% 70% 77% 62% 46% 35% 64% 44% 67% 23% 28% 17% 68% 73% 19% 27% 41% 60% 72% 6% 74% 22% 33% 31% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.3808964
GSM549102patient 115, normal, homogenized [OPG study]7.2140274
GSM549104patient 119, normal, homogenized [OPG study]4.2292523
GSM549108patient 138, normal, homogenized [OPG study]6.6695668
GSM549119patient 077, normal, homogenized [OPG study]6.9735472
GSM549133patient 032, cancer, homogenized [OPG study]4.8132537
GSM549139patient 042, cancer, homogenized [OPG study]4.4178627
GSM549099patient 107, normal, homogenized [OPG study]6.8988771
GSM549109patient 139, normal, homogenized [OPG study]7.0802573
GSM549110patient 046, normal, homogenized [OPG study]7.0764173
GSM549114patient 063, normal, homogenized [OPG study]6.3090563
GSM549122patient 082, normal, homogenized [OPG study]6.8646470
GSM549134patient 033, cancer, homogenized [OPG study]4.9669940
GSM549136patient 036, cancer, homogenized [OPG study]4.5831232
GSM549140patient 044, cancer, homogenized [OPG study]4.5504731
GSM549111patient 047, normal, homogenized [OPG study]4.6582433
GSM549113patient 057, normal, homogenized [OPG study]7.3351975
GSM549132patient 031, cancer, homogenized [OPG study]4.0594518
GSM549137patient 038, cancer, homogenized [OPG study]3.9257714
GSM549142patient 047, cancer, homogenized [OPG study]4.1293717
GSM549100patient 110, normal, homogenized [OPG study]6.8424870
GSM549107patient 135, normal, homogenized [OPG study]6.91170
GSM549115patient 068, normal, homogenized [OPG study]7.5926577
GSM549116patient 072, normal, homogenized [OPG study]6.2360662
GSM549120patient 078, normal, homogenized [OPG study]5.2886746
GSM549131patient 030, cancer, homogenized [OPG study]4.722335
GSM549118patient 074, normal, homogenized [OPG study]6.4073464
GSM549129patient 027, cancer, homogenized [OPG study]5.2262844
GSM549123patient 088, normal, homogenized [OPG study]6.660467
GSM549124patient 006, cancer, homogenized [OPG study]4.3038423
GSM549126patient 015, cancer, homogenized [OPG study]4.4646928
GSM549128patient 025, cancer, homogenized [OPG study]4.0065317
GSM549103patient 117, normal, homogenized [OPG study]6.6873368
GSM549117patient 073, normal, homogenized [OPG study]7.1158173
GSM549138patient 041, cancer, homogenized [OPG study]4.0991719
GSM549141patient 045, cancer, homogenized [OPG study]4.3563827
GSM549130patient 028, cancer, homogenized [OPG study]5.0383341
GSM549101patient 111, normal, homogenized [OPG study]6.1450760
GSM549105patient 128, normal, homogenized [OPG study]7.053472
GSM549106patient 134, normal, homogenized [OPG study]3.605996
GSM549112patient 048, normal, homogenized [OPG study]7.193274
GSM549125patient 011, cancer, homogenized [OPG study]4.2242222
GSM549127patient 024, cancer, homogenized [OPG study]4.674833
GSM549135patient 035, cancer, homogenized [OPG study]4.524331